Just caught Strata's Q4 earnings and the numbers are pretty solid. Revenue jumped 83.5% to $66.79M, which is a significant jump from the $36.39M they did a year ago. The stock popped 13.59% in pre-market trading after the announcement, closing around $5.10.

What's interesting is how the acquisition of Keystone mid-September is already moving the needle. Their clinical segment revenue shot up to $17.56M from just $2.8M the year before. Their organic logistics business also grew 35.3% to $49.2M, so it's not just the acquisition carrying them.

For the full year 2025, Strata pulled in $197.14M in total revenue, up 34.3% year-over-year. They also narrowed their net loss from continuing operations to $5.39M in Q4 versus $7.43M prior year, and adjusted EBITDA surged 547% to $6.96M.

Looking ahead, management raised their 2026 guidance to $260-$275M in revenue, which would be 32-39% growth from last year. They're also guiding adjusted EBITDA between $29-$33M for 2026. The co-CEOs mentioned they're working on multiple acquisition opportunities at reasonable valuations, so could see more moves.

Strata trades between $2.35 and $6.02 over the past year. Solid execution on integrating Keystone and growing the core business. Worth keeping an eye on if you follow healthcare logistics plays.